FDA NDC Directory · JSON-LD · Markdown

Unituxin

NDC 66302-014 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameDINUTUXIMAB
Labeler / ManufacturerUnited Therapeutics Corporation
Marketing categoryBiologic License Application · App BLA125516
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsDINUTUXIMAB (3.5 mg/mL)
Marketing started20150310
Package count1

External sources

Source: openFDA. Public-domain (CC0).